Abstract

Background
Types of Blocks
The following procedures have an established record of success in well-selected patients:
Celiac plexus block (CPB): Used for upper abdominal pain—most commonly from pancreatic cancer. It is also appropriate for pain involving the gastrointestinal (GI) tract from the distal third of the esophagus to the transverse colon, the liver and biliary tract, the adrenals, and mesentery. Superior hypogastric plexus block: Applicable to malignant pain of the GI tract from the descending colon to the rectum, as well as the urogenital system. Ganglion impar block: Pain involving the rectum and perineum.
Procedure
For CPB, patients are positioned supine or prone, according to operator preference and patient comfort. Patients are intravenously hydrated and sedated. The skin and underlying tissues are infiltrated with local anesthetic. Neurolytic blocks are often preceded by local anesthetic blocks to assess adequacy of analgesic response before executing a neurodestructive procedure. In the palliative setting, local anesthetic blocks are often waived due to logistical and patient comfort issues. Neurolytic procedures are always performed under fluoroscopic, computed tomography (CT), or endoscopic ultrasound to minimize potential for damage to organs and spinal cord. Blocks are performed with ethyl alcohol (50%–100%) or phenol (6%-10%). Neurolytic blocks may provide several months of analgesia and may be repeated.
Complications and Side Effects
Side effects—referable to loss of sympathetic tone—include transient hypotension and increased intestinal motility. Complications include needle injury to visceral, neural, and vascular structures; pain at the injection site; and failure to obtain an analgesic response. Contraindications to these procedures include bleeding diathesis and local infection.
Postprocedural Management
Crucial to the success of sympatholysis is proper patient selection and technical skill. Sympathetic blocks are not a panacea and generally do not obviate the need for ongoing pharmacological management of residual pain. However, they can substantially improve analgesia and quality of life, and may allow for opioid dosage reduction. Note: attempts at post-block opioid reduction should be done with care to avoid unmasking existing nociceptive/neuropathic pain and precipitating opioid withdrawal.
